KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Resmed (RMD) Non-Current Debt (2016 - 2017)

Resmed (RMD) has disclosed Non-Current Debt for 7 consecutive years, with $1.0 billion as the latest value for Q3 2017.

  • For the quarter ending Q3 2017, Non-Current Debt rose 16.64% year-over-year to $1.0 billion, compared with a TTM value of $1.0 billion through Sep 2017, up 16.64%, and an annual FY2017 reading of $1.1 billion, up 23.51% over the prior year.
  • Non-Current Debt was $1.0 billion for Q3 2017 at Resmed, down from $1.1 billion in the prior quarter.
  • Across five years, Non-Current Debt topped out at $1.2 billion in Q1 2017 and bottomed at $766000.0 in Q1 2013.
  • Average Non-Current Debt over 5 years is $523.1 million, with a median of $435.8 million recorded in 2013.
  • The sharpest move saw Non-Current Debt plummeted 99.7% in 2013, then surged 51569.06% in 2014.
  • Year by year, Non-Current Debt stood at $435.8 million in 2013, then grew by 3.18% to $449.7 million in 2014, then fell by 10.91% to $400.6 million in 2015, then soared by 116.85% to $868.7 million in 2016, then rose by 17.29% to $1.0 billion in 2017.
  • Business Quant data shows Non-Current Debt for RMD at $1.0 billion in Q3 2017, $1.1 billion in Q2 2017, and $1.2 billion in Q1 2017.